Barinthus Biotherapeutics Plc ADR (BRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 43,266 | 11,432 | N/A | N/A |
| Receivables | 3,226 | 3,908 | N/A | N/A |
| TOTAL | $47,901 | $16,249 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 629 | 520 | N/A | N/A |
| Other Non-Current Assets | 2,136 | 2,274 | 0 | 0 |
| TOTAL | $2,765 | $2,794 | $N/A | $N/A |
| Total Assets | $50,666 | $19,043 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 4,667 | 3,889 | 0 | 0 |
| Accrued Expenses | 2,537 | 1,421 | N/A | N/A |
| TOTAL | $7,641 | $5,752 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Deferred Revenues | 245 | 270 | N/A | N/A |
| Other Non-Current Liabilities | 80,164 | 37,339 | 0 | 0 |
| TOTAL | $79,937 | $35,371 | $N/A | $N/A |
| Total Liabilities | $87,578 | $41,122 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Retained earnings | -57,720 | -37,885 | N/A | N/A |
| Other shareholders' equity | -852 | -100 | 0 | 0 |
| TOTAL | $-36,912 | $-22,079 | $N/A | $N/A |
| Total Liabilities And Equity | $50,666 | $19,043 | $0 | $0 |